A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer
Overview
Authors
Affiliations
Ferroptosis is an iron-dependent, regulated form of cell death, and the process is complex, consisting of a variety of metabolites and biological molecules. Ovarian cancer (OC) is a highly malignant gynecologic tumor with a poor survival rate. However, the predictive role of ferroptosis-related genes in ovarian cancer prognosis remains unknown. In this study, we demonstrated that the 57 ferroptosis-related genes were expressed differently between ovarian cancer and normal ovarian tissue, and based on these genes, all OC cases can be well divided into 2 subgroups by applying consensus clustering. We utilized the least absolute shrinkage and selection operator (LASSO) cox regression model to develop a multigene risk signature from the TCGA cohort and then validated it in an OC cohort from the GEO database. A 5-gene signature was built and reveals a favorable predictive efficacy in both TCGA and GEO cohort ( < 0.001 and = 0.03). The GO and KEGG analysis revealed that the differentially expressed genes (DEGs) between the low- and high-risk subgroup divided by our risk model were associated with tumor immunity, and lower immune status in the high-risk group was discovered. In conclusion, ferroptosis-related genes are vital factors predicting the prognosis of OC and could be a novel potential treatment target.
Senescence-Related LncRNAs: Pioneering Indicators for Ovarian Cancer Outcomes.
Fan S, Xie X, Wei W, Hua T Phenomics. 2024; 4(4):379-393.
PMID: 39583315 PMC: 11584837. DOI: 10.1007/s43657-024-00163-z.
Yunyun Z, Guihu W, An J Front Immunol. 2024; 15:1458264.
PMID: 39478854 PMC: 11521951. DOI: 10.3389/fimmu.2024.1458264.
The recent advancements of ferroptosis of gynecological cancer.
Tang S, Chen L Cancer Cell Int. 2024; 24(1):351.
PMID: 39462352 PMC: 11520064. DOI: 10.1186/s12935-024-03537-5.
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer.
Chen S, Wang L, Lin Y, Chen C J Ovarian Res. 2024; 17(1):190.
PMID: 39342345 PMC: 11437962. DOI: 10.1186/s13048-024-01518-w.
Ferroptosis: mechanism, immunotherapy and role in ovarian cancer.
Guo K, Lu M, Bi J, Yao T, Gao J, Ren F Front Immunol. 2024; 15:1410018.
PMID: 39192972 PMC: 11347334. DOI: 10.3389/fimmu.2024.1410018.